The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Is it just me…… I thought OPTI said they wouldn’t sell any further? Looks like they sold something like 1.5 mill shares without declaring it. It's been announced solely because of the fundraise. Or have I got that wrong? Happy to be corrected.
That’s an impressive institution indeed! Very credible and always long term holders. As you say Toyin, they took half of the institutional capital placing. Well done guys.
One CEO who cut costs after 11 years selling a product and another who has been selling a product from a 2021 launch (2 years). Apples to apples.......... let's give SA another 9 years...... Is that your rationale?
I think comparing SBTX with OPTI isn't really apples to apples. Given that SA has launched a product (AxisBiotix) with no marketing team or any real marketing budget in the middle of a pandemic at a 60-65% GP and is selling circa £20-25k per month. Let's compare that to OPTI full year results issued on 28th June this year (RNS number 0841E) "Full year revenues from customer contracts of £457K." Looks like SBTX could be doing that next year at decent margins on a shoestring budget. OPTI has been at this since 2012...... that's 11 years. I know who I'm backing!
Significantly oversubscribed on the open offer and SA could have taken a lot more in the placing. I think he’s been extremely unfairly treated by TW. I often think Tom is balanced and fair but he’s gone way over the top on this one. That Bearcast was a very personal attack on a CEO who is a lot better than many of those on AIM. He was asked for the interviews by Elric (and they were good interviews too). He is doing a tough job in difficult times. Have you seen the levels of discounts being given at the moment? 60-70% in some cases, many companies simply can’t raise cash at all and he goes out and raises £3mill from Institutions and is “heavily over subscribed” on the open offer. I bought in at 9p, 16p, 22p, 38p and 47p and have bought in again on the offer. It looks like I’m scaled back so I will go again over the rest of this week to top up. This has so much potential on so many areas and TW wants him to sit back and wait for Croda. Madness. AIMHO, DYOR, GLA
I’m happy that’s done . Cash runway for more than a year, and lots in the pipeline. Not that big a discount given the current market. There are placings taking place at 50-60% discount. I’d say the risk has been minimised here and it’s all to play for. Happy indeed!
I think Oelric should probably stay off the boards. Mostly rude and on this occasion clearly drunk. Do us all a favour dear chap, go and dig a hole in your garden, sit in it and reflect on things that you might understand. Elrico's research is invaluable to those of us that are prepared to listen and often learn. You don't fall into that camp matey.
This is the bargain of the century at these prices. Nervous nellies selling down on the back of retail tipsters like Tom Winnifrith. Many of these so called “analysts” tipped this to be a superstar stock with 10 fold returns. One whisper of a raise and the market goes into freefall. Really dumb behaviour. I can’t see SA or anyone leaking news? Why would they? What’s to gain from their perspective? This is simply the rumour mill fuelled by fools. Even if he does raise to get to profitability, isn’t that a good thing? As the great Warren Buffet says “be greedy when others are fearful and fearful when others are greedy”
Well said Clio, I have every confidence that SA will not issue any more stock than is needed. As you rightly say, he has significant options to achieve and an over placement would be counter productive to that. A revenue generating, profitable acquisition (or multiple) on the other hand would quite literally "transform" our prospects.
There really are some very silly sells taking place. Give the guy a chance for heavens sake. He said an acquisition by year end not month end. I guess some people simply don't understand the M&A angle and what that strength that brings the company when negotiating wider deals with multinationals. I will continue to top up wherever funds allow. GLA, DYOR
And they’re off again! Pesky Market Makers playing their silly games once again. Surely this should be illegal? It’s certainly unethical. Keep the faith Brothers and Sisters. This one is going to deliver and deliver big!
Having read and re-read last weeks RNS and the Croda release from the previous week I think we are set for a bit of a run. As Elric mentions, the last time we looked like this we ran into the 75p zone really quickly. If SA has more options at 80p then that has to be a target for him. GLA!
I believe that is more than covered in Dr Kelly’s statement that the clinicals will be concluded in “early” 2024. He literally says just that. He also goes on to add that commercial grade bulk product is to be manufactured and let’s face it, they wouldn’t do that without a launch plan for next year. Finally, with regards to the financial payment……… Croda are paying for the clinical trial to achieve evidence to support a higher price point, of which we receive double digit royalties. I’m not sure where your confusion lies. All your negative comments achieve is the share price being driven down by lemmings and as such our investment is worth less than it was this morning. Hopefully SA will conduct his usual round of interviews and clear some of the fog. I for one believe it is an excellent RNS. Each to their own I guess.
I’m afraid there are a lot of day traders out there with zero patience or vision. They make the small Halfpenny gains and the long term investors reap the big gains as just rewards for loyalty and our understanding of the strategy. A FTSE 100 giant states that the clinicals will be completed early 2024 and revenues follow right after that and someone sells……. Go figure! I can’t understand the mentality of that at all.
What an excellent update that hits the spot for me. Confirmation that we have granted a 12 month extension to the development programme which expires next month so Sederma / Croda have to have an extension to continue but Dr Kelly goes on to clearly state that the clinical work will be completed “early 2024”. He talks of “premium quality formulations” that’s plural….. these releases are fact checked by Croda lawyers and by our lawyers to ensure accuracy, “have also been developed” this indicates that the VIPs have stabilised their formulations already. Commercial scale up in the UK this year with test batches already completed. I believe these test batches are the ones that were already sent out to VIPs and turned into those “premium quality formulations” that he mentions. It’s a minor delay for a much greater prize. Croda need new innovative products as we all know, this is it! SA promised more news flow before year end and now it begins. We could do with a statement on acne next please. Happy holder here and I will gladly top up when funds allow.
Mol, please remember that SA has vested share options of something like. 1.3 million shares from his option pool. He triggered them when we went over 40p. MR probably has options too, likewise the Chairman and the rest of the board.
Raytheg, that’s the silliest comment I’ve seen on this board for a while, and you’re up against some serious competition. SA is probably the most responsive CEO on AIM. Toyin nails the answer . 2 interviews this month. You should probably move onto another share. You’re way out of your depth here. Oelric, you’ve spent a year posting scathing comments on here. “Off the coast of Sardinia” but can’t afford £30. Do me a solid mate and move on. This one is going to go through the bloody roof! If you don’t believe then stay in your mythical Sardinia.
Todays decline solely down to Gary Newman’s dumb comments following Tom Winnifrith’s rather good interview. Newman has clearly done the square root of nothing when it comes to research on SBTX. Non regulated amateurs of this nature should be banned from making such sweeping statements. Standby for a drop on SBTX and OPTI before people realise he is totally and utterly incorrect on every point he makes. I can’t believe I’m saying this but “well done Tom on correcting the fool”
A solid interview. SA came across as calm and collected. Exactly what you want in a CEO. Very happy to hold here and add where funds allow.